Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GATC Biotech Offers World´s Fastest Exome Sequencing Service

Published: Friday, June 07, 2013
Last Updated: Friday, June 07, 2013
Bookmark and Share
InView™ 1-Week Exome Diagnostic for the detection of cancerous cells or other genetic diseases.

GATC Biotech has designed InView™ 1-Week Exome Diagnostic especially for diagnostic purposes. This service enables early detection of multiple genetic variants presumably responsible for diverse genetic disease markers within just 7 days, the world’s fastest turn-around time available.

With its DIN EN ISO/IEC 17025 certified Next Gen Sequencing laboratories, GATC Biotech offers this application e.g. for detection of cancerous cells or early detection of other genetic diseases.

The application supports clinicians to initiate urgent treatments and opens the way to a more personalized patient care in the field of cancer, metabolic dysfunctions and immunological diseases.

With a combination of standardized workflows and highest quality standards, InView™ 1-Week Exome Diagnostic is an overall solution for fast and reliable variant detection.

Focusing on the functional relevant coding regions, only approx. 1% of the human genome (the exome) needs to be sequenced. This provides an efficient advantage for diagnostics and clinical research.

“Next Generation Sequencing technologies have set a new level in the field of clinical research and diagnostics. 1-Week Exome Diagnostic is an all-in-one service delivering rapid results for early detection of diseases for our customers in diagnostics, clinical and pharmaceutical research”, tells Dr. Marcus Benz, COO at GATC Biotech.

Dr. Benz continued, “Being the leading service provider for NGS solutions, scientists can profit from our thorough experience in exome analysis while receiving accurate results in only 7 days.”

Essential requirements for the competence of analysis and calibration laboratories such as DIN EN ISO/IEC 17025 and DIN EN ISO 9001 by the national accreditation body for the Federal Republic of Germany (DAkkS) have been fulfilled by GATC Biotech’s NGS laboratories.

The application is based on Agilent SureSelectXT Human All Exon V5 enrichment and Illumina MiSeq.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GATC Biotech Opens Third Sequencing Laboratory in Europe
Facilities will be situated in Düsseldorf, Germany.
Wednesday, November 17, 2010
GATC Biotech to Sequence 100,000 Human Genomes by 2014
PacBio RS to support studies on rare variant, and structural variations and methylation patterns.
Wednesday, September 29, 2010
GATC Biotech Sequences Pediatric Brain Tumors for the International Cancer Genome Consortium
GATC Biotech to sequence samples from brain tumors in children for the world’s largest cancer research project.
Tuesday, May 18, 2010
GATC Biotech Orders Europe’s First HiSeq 2000 for Commercial Use
Illumina’s latest sequencing system to be installed in the Constance laboratories.
Friday, January 22, 2010
GATC Biotech Launches Human Genome Sequencing Service at BioEurope
GATC hopes to boost the move towards personalized medicine by sequencing up to 100 genomes by the end of 2010.
Friday, November 16, 2007
GATC Biotech will use Genome Sequencer Technology from Roche
GATC plans to use the Genome Sequencer to offer its customers all the applications within this technology, with a special focus on in-depth analysis of whole transcriptomes.
Wednesday, March 07, 2007
Scientific News
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Regulatory RNA Essential to DNA Damage Response
Researchers discover a tumour suppressor is stabilized by an RNA molecule, which helps cells respond to DNA damage.
Death-or-Repair Switch Protein Identified
Researchers have identified a protein that plays a key role in the decision process of cell damage repair or cellular suicide.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Wearable Microscope Can Measure Fluorescent Dyes Through Skin
UCLA research could make monitoring disease biomarkers easier and more cost-effective.
“Sixth Sense” More Than a Feeling
NIH study of rare genetic disorder reveals importance of touch and body awareness.
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!